Cargando…
2例免疫检查点抑制剂联合化疗引发2型糖尿病个案报道
Immune checkpoint inhibitors (ICIs) have become an important means of cancer treatment, and their application in the clinic is becoming more and more widespread. The adverse reactions caused by ICIs are gradually recognized. Among them, immunotherapy-related diabetes is a rare adverse reaction and t...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051303/ https://www.ncbi.nlm.nih.gov/pubmed/35477193 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.10 |